Best of the Week
Most Popular
1. Market Decline Will Lead To Pension Collapse, USD Devaluation, And NWO - Raymond_Matison
2.Uber’s Nightmare Has Just Started - Stephen_McBride
3.Stock Market Crash Black Swan Event Set Up Sept 12th? - Brad_Gudgeon
4.GDow Stock Market Trend Forecast Update - Nadeem_Walayat
5.Gold Significant Correction Has Started - Clive_Maund
6.British Pound GBP vs Brexit Chaos Timeline - Nadeem_Walayat
7.Cameco Crash, Uranium Sector Won’t Catch a break - Richard_Mills
8.Recession 2020 Forecast : The New Risks & New Profits Of A Grand Experiment - Dan_Amerman
9.Gold When Global Insanity Prevails - Michael Ballanger
10.UK General Election Forecast 2019 - Betting Market Odds - Nadeem_Walayat
Last 7 days
UK House Prices Most Accurate Predictor of UK General Elections - 2019 - 5th Dec 19
7 Year Cycles Can Be Powerful And Gold Just Started One - 5th Dec 19
Lib Dems Winning Election Leaflets War Against Labour - Sheffield Hallam 2019 - 5th Dec 19
Do you like to venture out? Test yourself and see what we propose for you - 5th Dec 19
Great Ways To Make Money Over Time - 5th Dec 19
Calculating Your Personal Cost If Stock, Bond and House Prices Return To Average - 4th Dec 19
Will Labour Government Plant More Tree's than Council's Like Sheffield Fell? - 4th Dec 19
What the UK Economy GDP Growth Rate Predicts for General Election 2019 - 4th Dec 19
Gold, Silver and Stock Market Big Picture: Seat Belts Tightened - 4th Dec 19
Online Presence: What You Need to Know About What Others Know About You - 4th Dec 19
New Company Tip: How To Turn Prospects into Customers with CRM Tech - 4th Dec 19
About To Relive The 2007 US Housing Market Real Estate Crash Again? - 3rd Dec 19
How Far Will Gold Reach Before the Upcoming Reversal? - 3rd Dec 19
Is The Current Stock Market Rally A True Valuation Rally or Euphoria? - 3rd Dec 19
Why Shale Oil Not Viable at $45WTI Anymore, OPEC Can Dictate Price Again - 3rd Dec 19
Lib Dem Election Dodgy Leaflets - Sheffield Hallam Battle General Election 2019 - 3rd Dec 19
Land Rover Discovery Sport Brake Pads Uneven Wear Dash Warning Message at 2mm Mark - 3rd Dec 19
The Rise and Evolution of Bitcoin - 3rd Dec 19
Virtual games and sport, which has one related to the other - 3rd Dec 19
The Narrative About Gold is Changing Again - 2nd Dec 19
Stock Market Liquidity & Volume Diminish – What Next? - 2nd Dec 19
A Complete Guide To Finding The Best CFD Broker - 2nd Dec 19
See You On The Dark Side Of The Moon - 2nd Dec 19
Will Lib Dems Win Sheffield Hallam From Labour? General Election 2019 - 2nd Dec 19
Stock Market Where Are We?  - 1st Dec 19
Will Labour's Insane Manifesto Spending Plans Bankrupt Britain? - 1st Dec 19
Labour vs Tory Manifesto Debt Fuelled Voter Bribes Impact on UK General Election - 30th Nov 19
Growing Inequality Unrest Threatens Mining Industry - 30th Nov 19
Conspiracy Theories Are Killing This Nation - 30th Nov 19
How to Clip a Budgies / Parakeets Wings, Cut / Trim Bird's Flight Feathers - 30th Nov 19
Hidden Failure of SIFI Banks - 29th Nov 19
Use the “Ferrari Pattern” to Predictably Make 431% with IPOs - 29th Nov 19
Tax-Loss Selling Drives Down Gold and Silver Junior Stock Prices - 29th Nov 19
We Are on the Brink of the Second Great Depression - 29th Nov 19
How to Spot REAL Amazon Black Friday Bargains and Avoid FAKE Sales - 29th Nov 19
Central Banks’ Gold Buying and Repatriation Spree - 28th Nov 19
Another Precious Metals’ Reversal Coming Right Up! - 28th Nov 19
Stock Market 100% Measured Moves May Signal A Top - 28th Nov 19
Don’t Look for Investing Advice in the Media - 28th Nov 19
Why You Should Buy Trailer Park Stocks - 28th Nov 19
Will YouGov General Election Forecast 2019 be as Wrong as their REAL Forecast was for 2017? - 28th Nov 19

Market Oracle FREE Newsletter

UK House prices predicting general election result

Obamacare Proof Stocks

Companies / Healthcare Sector Apr 17, 2014 - 04:08 PM GMT

By: Money_Morning


Now that all the key deadlines for Obamacare have finally taken effect, a lot of tech investors are busy trying to figure out how this will affect their portfolios.

It's easy to see why. This is the largest and most fundamental change to hit the healthcare sector in decades.

Not only that, but Wall Street is currently trying to pick the winners from the losers - and frankly isn't doing a particularly good job of it.

Fact is, Obamacare is at least partly responsible for some of the biotech sector's recent sell-off...

The Government Hammer Falls on Biotechs

For example, industry analysts recently cited the impact of a letter sent last month by several House members questioning the price of a blockbuster drug used to treat hepatitis C.

The issue was the cost of Sovaldi, a drug sold by Gilead Sciences Inc. (Nasdaq: GILD). Solvaldi costs $84,000 a year but is a godsend to patients because it helps prevent the need for a liver transplant that costs some $250,000 - assuming you can find a donor organ.

That missive roiled the biotech sector because many investors feared politics in advance of the mid-term elections might affect other medical technologies.

I think that's a classic overreaction in a jittery market. But it does bring up a very important point.

What investors really need to look for are stocks that are what I call "Obamacare-proof."

By that I mean we need to find companies that will profit over the long haul whether Obamacare remains in effect or not.

Let's assume for the moment that the Republicans hold the House and take the Senate this November and capture the White House in 2016. And let's further assume they gut the Affordable Care Act.

Even in that scenario, there is one sector that will continue to do well. The reason is that we'll still need a key piece of technology that can help rein in rising healthcare costs no matter what the political landscape looks like.

That's why an area broadly defined as healthcare information technology (IT) services will continue to play a crucial role in America's future.

So, today I want to examine this sector in some detail. First, I want to look at examples of new IPOs in the space. Then, to give you a heads up on long-term profit plays, I'm going to identify two promising startups on an IPO track.

And then I'll conclude by identifying what I think is one of the better Obamacare-proof stocks out there today.

So let's get started by looking at those two recent health IT public offerings.

Public Offering No. 1

Enterprise Healthcare Software

Castlight Health Inc. (NYSE: CSLT) is a leader of enterprise healthcare software. It operates a web platform that assists patients in understanding various aspects of their healthcare benefits, including coverage, costs, and preferences.

Founded in 2008, the San Francisco-based company's March IPO was one of the more highly anticipated new issues so far this year. It did not disappoint, quickly jumping almost 150% to around $40 a share, and raising $178 million.

Leading up to its market debut, the stock had a series of price upgrades, but eventually landed at $16 a share. At its peak, the stock's market cap was around $3 billion.

No doubt, it has given up nearly all of its gains during the tech sector's retreat. But at deadline it was still trading above its entry price and poised to go higher.

Public Offering No. 2

Digital Health & Wellness

Meantime, Everyday Health Inc. (NYSE: EVDY) is a health and wellness digital media company. Its portfolio includes some of the most popular health and wellness websites on the Internet, including and It also hosts PC and mobile apps for counting food calories and tracking fitness activities.

In total, the company operates 25 websites and 31 social media accounts. According to Fortune, one-third of U.S. physicians used Everyday Health's services in 2013, while 132 million unique visitors accessed the company's websites.

Everyday Health launched its offering in March at $14 a share, raising more than $110 million, and is trading right near that level.

But remember, we're not focused on the daily market action. We're looking at this area as playing a vital service for doctors, patients, and government agencies for many years to come.

That's why investors would do well to put two private companies in the sector on their radar screens. Both are getting a lot attention from venture capital firms and look like great candidates for successful IPOs.

Lock In on These Two Companies, Pre-IPO

Take the case of MindBody Inc. This is a provider of online marketing tools for clients in the health, wellness, and beauty industries. The company offers a suite of tools including networking capabilities, scheduling software, website analytics, and point-of-sale systems.

Over 33,000 businesses in 100 countries have used MindBody's marketing tools. Its MindBody Connect mobile app is also immensely popular with health and wellness practitioners.

Inc. magazine has ranked MindBody as one of the fastest-growing companies for the last six straight years. And from a funding perspective, there has been considerable venture capital money being funneled into MindBody, including $50 million from Montreux Equity Partners and Bessemer Venture Partners.

For its part, MedHOK Inc. offers software and cloud-based solutions to aid with everything from healthcare plans to specialty pharmacies. MedHOK has an extensive range of services it provides through one main platform, which gives the company a competitive advantage in the health IT sector.

By providing software-as-a-service, MedHOK offers its clients essential programs based in the cloud. The company has garnered upwards of $77.5 million in venture capital funding from firms like Bain Capital Ventures and Spectrum Equity.

Pick This Winner for Any Market

Now then, as much as we like several companies in this space, we think investors would do well to take a close look at IMS Health Holdings Inc. (NYSE: IMS).

The company remains the world's leading provider of sales and market research data to companies in the healthcare industry. It is a Big Data firm working exclusively in the healthcare industry and has shown stability in its financials and price performance.

From doctors and clinical researchers, to hospitals and biopharmaceutical companies, IMS Health supports the industry by providing the necessary data to benefit organizations and patients. The company does so by linking more than 100,000 data suppliers and working with over 9,500 healthcare professionals in 100 countries.

IMS stores patient data securely and anonymously in the cloud while processing over 45 billion healthcare transactions each year. The company's recent IPO at $20 a share raised more than $1.3 billion.

But this is a company and stock with enormous upside potential. IMS posted a profit of $82 million, with $2.5 billion in sales for 2013. That's a profit performance for a growth company that has recently gone public.

Over the long run, IMS should continue to do well. It has the right products for the right market at a time when the nation needs to stem the rise in healthcare costs.

So, investors who can look beyond the market's sell-off should do extremely well with this great Obamacare-proof stock.

Source :

Money Morning/The Money Map Report

©2014 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email:

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Money Morning Archive

© 2005-2019 - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.

Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules